In recent years, SAMHD1 has been proposed as a prognostic marker mainly in different types of hematological cancers, but also to a lesser extent in different solid tumors such as NSCLC and colorectal cancer [44]. Here, SAMHD1 is linked to hematopoietic and lymphoid cell neoplasm.